We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
#3577 Peritoneal infusion of microplastics induces over-expression of GDF-15 in kidney and heart in mice
AI summary Read the abstract
This conference abstract studied peritoneal infusion of microplastics in patients with chronic kidney disease undergoing dialysis, finding elevated GDF-15 (a stress and inflammation biomarker) in association with MP exposure. The findings suggest that peritoneal dialysis patients face heightened risks from microplastic contamination in dialysis materials.
Abstract Background and Aims There is growing concern regarding the potential impact of microplastics (MPs) on human health. Patients with chronic kidney disease (CKD) undergoing peritoneal dialysis may be particularly vulnerable to exposure to these particles. Recent findings have demonstrated the presence of microplastics in human urine and kidney tissue, highlighting the potential toxicity of these substances. In light of these concerns, we aimed to investigate the effects of microplastics on kidney and heart tissues, with a particular focus on the expression of GDF-15. GDF-15 (growth differentiation factor 15) is a cytokine involved in various biological processes, including the inhibition of apoptosis and the modulation of inflammation under several pathological conditions. As a member of the TGF-beta family, GDF-15 is expressed in numerous tissues and plays a key role in oxidative stress and mitochondrial dysfunction. Elevated levels of GDF-15 have been associated with an increased risk of mortality, the onset of CKD, and its progression in individuals with renal impairment. In a recent proteomic study (data not yet published), we identified GDF-15 as a potential biomarker for microplastic exposure in kidney tubular cells. Method Eight-week-old male BL/6 mice were housed in standard cages with ad libitum access to chow and water. Green Fluorescent Polymer Microspheres (FMG, maximum excitation wavelength 515 nm), with a diameter range of 1–5 μm, were purchased from Cospheric LLC (Santa Barbara, USA). The mice were administered 0.25 mg of FMG, diluted in deionized water (total volume of 150 μl), via intraperitoneal injection. This treatment was repeated three times a week for a duration of four weeks. No acute adverse effects were observed following the administrations. Urine samples were collected at various time points until sacrifice. Mice that received FMG treatment, along with one untreated control mouse, were sacrificed 30 days after the first dose to collect blood serum, and kidney, heart, liver, and spleen tissues. Immunohistochemical staining for GDF-15 was performed on kidney and heart tissue sections. Results Our analysis revealed the deposition of microplastics in both kidney and heart tissues following peritoneal administration. GDF-15 expression was significantly increased in the heart (P = 0.02) and kidney (P < 0.0001) tissues (Figs 1 and 2). Conclusion Our findings demonstrate that microplastics, when administered via the peritoneal route, are detectable in target organs such as the kidney and heart. Furthermore, exposure to microplastics leads to a significant overexpression of GDF-15, a cytokine that may serve as a potential biomarker for inflammation in these tissues. This study provides valuable insights into the toxicological effects of microplastic exposure on organ systems and underscores the need for further investigation into the role of GDF-15 as a potential marker of exposure-related inflammation.
More Papers Like This
Effects of microplastics and nanoplastics on the kidney and cardiovascular system
AI summary Read the abstract
This review summarizes evidence that microplastics and nanoplastics found in human hearts, kidneys, blood, and urine can cause oxidative stress, inflammation, cell death, and metabolic disruption. Kidney dialysis patients may face especially high exposure, and clinical evidence suggests particulate plastic exposure is a risk factor for cardiovascular disease.
Micro- and nanoplastics and the kidney: human evidence, clinical vulnerabilities, dialysis-related exposure, and CKD
AI summary Read the abstract
Tiny plastic particles have been found in human kidneys, blood, and urine, and this review pulls together existing research suggesting these particles—along with chemicals like BPA and PFAS often found in plastics—may be linked to kidney damage, high blood pressure, and chronic kidney disease. People on dialysis may face extra exposure because their blood repeatedly contacts plastic tubing and filters during treatment, making them an important group to study further. While the science is still developing, this research highlights why reducing plastic exposure and rethinking medical device materials could matter for protecting kidney health, especially in vulnerable patients.
Polystyrene Microplastics Activate Noncanonical TGF-β Signaling and Metabolomic Reprogramming to Promote Epithelial-Mesenchymal Transition and Fibrosis in the Kidney
AI summary Read the abstract
In a mouse study, tiny plastic particles called microplastics (commonly found in food, water, and even human organs) built up in the kidneys and triggered changes linked to scarring and declining kidney function, along with shifts in metabolism similar to those seen in chronic kidney disease. While this research was done in mice and cells rather than people, it adds to growing evidence that the microplastics we're constantly exposed to may pose real risks to kidney health over time.
Toxicological effects of microplastics in renal ischemia–reperfusion injury
AI summary Read the abstract
Researchers studied how microplastic exposure affects kidney injury and recovery in a mouse model of reduced blood flow to the kidneys. They found that microplastics worsened kidney damage by triggering inflammatory responses and disrupting cellular repair processes. The study suggests that microplastic accumulation in the body may increase vulnerability to kidney complications.
Polystyrene microplastics exacerbate experimental chronic kidney disease via inflammatory and oxidative pathways involving NF-κB, ERK/p38 MAPK, and sirtuin-1
AI summary Read the abstract
Researchers examined the effects of polystyrene microplastics on mice with chronic kidney disease and found that microplastic exposure worsened kidney dysfunction, inflammation, and tissue scarring. Even in healthy mice, microplastics reduced kidney filtration and increased markers of kidney damage. The study suggests that microplastic exposure may aggravate existing kidney conditions through inflammatory and oxidative stress pathways.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.